Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

Registry ID
EUCTR2016-000635-40
Source registry
EUCTR
Phase
PHASE2
Sponsor
UCB BIOSCIENCES, Inc.
Last update
2026-08-16

Conditions

Summary

The primary objective of this study is to assess the long-term safety and tolerability of rotigotine treatment in adolescents with idiopathic restless legs syndrome (RLS).

Related clinical trials

View on source registry